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Precise control of the thyroid hormone (T3)-depen-
dent transcriptional program is required by multiple
cell systems, including muscle stem cells. Decipher-
ing how this is achieved and how the T3 signal is
controlled in stem cell niches is essentially unknown.
We report that in response to proliferative stimuli
such as acute skeletal muscle injury, type 3 deiodi-
nase (D3), the thyroid hormone-inactivating enzyme,
is induced in satellite cells where it reduces intracel-
lular thyroid signaling. Satellite cell-specific genetic
ablation of dio3 severely impairs skeletal muscle
regeneration. This impairment is due to massive
satellite cell apoptosis caused by exposure of acti-
vated satellite cells to the circulating TH. The execu-
tion of this proapoptotic program requires an intact
FoxO3/MyoD axis, both genes positively regulated
by intracellular TH. Thus, D3 is dynamically exploited
in vivo to chronically attenuate TH signaling under
basal conditions while also being available to acutely
increase gene programs required for satellite cell
lineage progression.
INTRODUCTION
Muscle regeneration is a multistep process that includes
myofiber degradation, regeneration, and remodeling (Ten Broek
et al., 2010). The repair process is characterized by the activa-
tion of a primary myogenic stem cell population referred to as
‘‘satellite cells,’’ which give rise to activated proliferating myo-
blasts or myoblast precursor cells (mpcs), followed by cell differ-
entiation and fusion into regenerated myofibers. Satellite cells,1038 Cell Metabolism 20, 1038–1048, December 2, 2014 ª2014 Thethat are normally quiescent, can be activated to proliferate and
generate committed progeny in response to a variety of stimuli,
including degenerative muscle diseases (Brack and Rando,
2012; Dhawan and Rando, 2005; Rudnicki et al., 2008).
The active thyroid hormone (TH), T3, derives in large part from
themonodeiodination of the prohormone thyroxine (T4) by one of
two iodothyronine selenodeiodinases (D1 or D2). Conversely, TH
signaling terminates consequent to inactivation of T3 and T4
induced by removal of a tyrosyl ring iodine by type 3 deiodinase
(D3). D3 converts the active hormone T3 to inactive metabolites
thereby terminating TH action within cells. This provides amech-
anism by which TH action can be terminated in a tissue-specific
chronologically programmed fashion (Bianco et al., 2002). The
high expression of D3 in fetal compartments and the growth
retardation and partial neonatal mortality of D3-null mice
(Hernandez et al., 2006) confirm that D3 exerts a critical function
during development.
Normal TH levels are required for efficient muscle homeosta-
sis, function, and regeneration (McIntosh et al., 1994; Simonides
and van Hardeveld, 2008). Muscle is a major target of TH
action. Indeed, a broad set of genes are positively or negatively
regulated at the transcriptional level by TH (Salvatore et al.,
2014; Simonides and van Hardeveld, 2008). One of the genes
transcriptionally stimulated by T3 is MyoD (Muscat et al., 1995),
which is a master regulator of the myogenic developmental and
regeneration program.While it is well known thatmuscle function
is altered in patients with thyrotoxicosis or hypothyroidism, it has
also been shown that TH excess impairs the regeneration pro-
cess in the mdx mouse (Anderson et al., 1994). The pathophysi-
ological mechanism underlying this effect is unknown.
There are two sources of T3 in muscle tissue; one is the frac-
tion that enters the cells directly from the plasma, the second is
locally produced from T4-to-T3 conversion via D2 action (Den-
tice et al., 2010; Marsili et al., 2011). The factors involved in the
modulation of TH availability at cell level are unknown. Similarly,
little is known about how the balance between the T3-activatingAuthors
Figure 1. Type 3 D3 Is Highly Expressed in
Proliferating Muscle Precursor Cells and in
Pax7-Positive Cells in Skeletal Muscle
(A) Type 3 deiodinase (D3) protein (inset top)
and mRNA (inset bottom) levels in mouse GFP-
sorted (FACS) satellite cells isolated from
Tg:Pax7nGFP+ mice grown in culture under
proliferative (PROL) or differentiating (DIFF)
conditions.
(B) Immunofluorescence staining (IF) for D3, EdU,
MHC, DAPI, andmerged images in PROL andDIFF
FACS-sorted Pax7-GFP-positive cells. Scale bar,
50 mm.
(C) D3 (red)- and Pax7 (green)-positive cells
detected by IF in fibers cultured for 0, 24, and 72 hr
(scale bar, 50 mm).
(D) D3 enzymatic activity in different muscles from
control (WT) and mdx mice. Data are expressed
as mean ± SEM of at least three independent
experiments.
(E) D3 protein (top) and mRNA (bottom) measured
by western blot and RT-PCR in uninjured muscles
(0) and injured muscles (4–15) at different stages of
muscle regeneration induced by cardiotoxin (CTX)
injection into the tibialis anterior (TA) muscle.
(F) D3 enzymatic activity in TA muscles during
muscle regeneration induced by CTX injection.
For (A) and (D)–(F) data are expressed as mean ±
SEM of at least three independent experiments.
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D3 and the TH Signaling in Muscle Stem Cellsand -inactivating deiodinases inmuscle and inmuscle progenitor
cells is determined. Clarification of these issues would be a sig-
nificant advance in the understanding of the cellular pathways
governing the progression of muscle stem cell lineage.
The aim of our study was to dissect the role of the intracellular
TH metabolism and signaling in muscle progenitor cells. We
identified D3 in satellite cells and mpcs, and found that it is
induced upon stem cell activation early after muscle injury.
This event was associated with the expansion of the satellite
cell population that occurs after muscle injury. Despite normal
plasma T3 concentrations, selective depletion of D3 in the satel-
lite cell compartment resulted in severe cell apoptosis thereby
disrupting the normal pattern of tissue response to acute injury
and causing a marked delay in muscle regeneration. Thus, we
demonstrate that D3 and modulation of local TH metabolism
represent a survival mechanism during the progression of the
muscle stem cell lineage.
RESULTS
Upregulation of D3 in Proliferating Satellite Cells during
Muscle Regeneration
ToassesswhetherD3 is expressed in satellite cells,wemeasured
its expression in FACS-sorted cells from Tg:Pax7-nGFP mice
(Rocheteau et al., 2012) and found elevated D3 levels, whichCell Metabolism 20, 1038–1048, Ddeclinedasdifferentiationproceeded (Fig-
ures 1Aand1B), a pattern observedalso in
C2C12 as well as in primary cultures of
skeletal muscle enriched in satellite cells
(pp6 cells; Qu et al., 1998) (Figure S1A
available online). D3 levels increasedrapidly during muscle development, and peaked in the second
postnatal week, after which they progressively declined to reach
very low levels in the adult (Figure S1B). D3 expression, detect-
able in isolated Pax7-positive cells, increased in dividing
MyoD1-positivecells ofmuscle fibers (Figures1CandS1C). Inter-
estingly, D3 activity in limb muscles was significantly higher in
the dystrophic mdx mouse than in controls (Figure 1D), which is
consistent with the increased proliferation of satellite cells in the
dystrophic context.
We examined D3 expression during regeneration after cardio-
toxin (CTX) injection (Charge´ and Rudnicki, 2004). D3 mRNA,
protein, and enzymatic activity were significantly increased at
early stages after CTX injection (4–8 days) in the tibialis anterior
(TA) muscle. Then D3 declined, reaching nearly normal adult
levels by day 15 (Figures 1E and 1F). Coimmunofluorescence
analysis showed D3 staining in the Pax7-positive cells as well
as in the newly regenerating fibers and in F4/80+ macrophages
infiltrating the injury site (Figures 2A and 2B). D3 showed a dy-
namic cell-type specific expression, i.e., a robust expression at
day 7 in the satellite cell compartment and declined thereafter
(Figures 2A and 2B).
TH Signaling in Satellite Cells and D3 Expression
To determine whether D3might serve as a novel marker of a spe-
cific subset of Pax7-positive cells, we isolated satellite cells andecember 2, 2014 ª2014 The Authors 1039
Figure 2. D3 Is Induced in the Early Phases of Muscle Regeneration
(A) Left: immunofluorescence of D3 (red), MHC, F4/80, and Pax7 (green), and merged images in tibialis anterior (TA) muscles at days 0, 7, and 15 of muscle
regeneration. Right: immunofluorescence of D3 (red), Pax7, F4/80, and Desmin (green), DAPI (blue), and merged images of TA muscles at day 7 of muscle
regeneration.
(B) Quantification of percentage of D3-positive cells in muscle section at 7 days of regeneration (top) and in specific cell populations (bottom) after damage.
(C) D3 mRNA levels in subpopulations of quiescent (adult) and activated Pax7-nGFPHi, Pax7-nGFPmid, and Pax7-nGFPLo cells isolated as described under
Experimental Procedures. Activated satellite cells were obtained 5 days after TA injury. Normalized copies of D3 in quiescent, Pax7Hi cells were arbitrarily set as 1.
Data are expressed as mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.
(D) TH-responsive gene expression measured by RT-PCR in the same samples as in (C). Data are expressed as mean ± SEM of at least three independent
experiments.
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D3 and the TH Signaling in Muscle Stem Cellsfractionated them according to nGFP intensity by flow cytome-
try. We analyzed FACS-isolated Pax7-nGFPHi (top 20%), Pax7-
nGFPMid (intermediate 60%), and Pax7-nGFPLo (bottom 20%)
from CTX-injured or control-uninjured muscles. Interestingly,
within the Pax7-nGFP-expressing cells, D3 expression was
higher in Pax7-nGFPLo cells, which have the highest commit-
ment to progress toward a myogenic lineage (Figure 2C) (Mour-
ikis et al., 2012).Within theD3-positive Pax7-nGFPLo fraction, D3
expression inversely correlated with TH signaling. This is illus-
trated by the expression profile of well-characterized positively
(SerCa2, FoxO3, PGC-1a, Troponin 2) and negatively (PGC-1b
and Troponin 1) (Figures 2D and S2) regulated TH target genes,
which points to a relatively ‘‘hypothyroid state’’ in the Pax7-
nGFPLo/D3high-expressing cells (Figure 2D). The pattern of D31040 Cell Metabolism 20, 1038–1048, December 2, 2014 ª2014 Theexpression and the expression profile of the TH-responsive
gene in GFP-sorted cells provide functional evidence that intra-
cellular TH concentrations are tightly regulated in satellite cells
during lineage progression.
Effective Satellite Cell D3 Deletion in a Conditional
dio3-Null Mouse
We next asked what role D3 plays in proliferating myoblast pre-
cursors. To this aim, we generated a satellite cell-specific condi-
tional dio3 knockout mouse (see Experimental Procedures). The
homozygous dio3fl/fl mice were viable and fertile, with no alter-
ations in D3 protein, body mass, fertility, or serum TH concentra-
tions (Figures S1 and S3; data not shown). Adeno-Cre infection
of primary myoblasts resulted in effective deletion of theAuthors
Figure 3. Conditional Pax7-Specific D3
Knockout Mice
(A) Diagram of the experimental design used for
CTX and tamoxifen (TAM) injection.
(B) IF of D3 and Pax7 in the TA of control (WT) and
cD3KOmice treated with TAM as indicated 7 days
after injury. Scale bar, 25 mm.
(C) Percentage of Pax7- and TUNEL-positive cells
evaluated by IF in TA 7 days after injury. Data are
expressed as mean ± SEM of at least three inde-
pendent experiments. *p < 0.05.
(D) IF of Pax7- (red) and TUNEL-positive (green)
cells in CTX-injured TA of euthyroid control (CTR
EU), euthyroid cD3KO (cD3KO EU), and hypothy-
roid cD3KO (cD3KO HYPO) mice treated with TAM
as indicated. Scale bar, 50 mm.
(E) Quantification of double-Pax7/TUNEL-positive
cells from the experiment in (D). Data are ex-
pressed as mean ± SEM of at least three inde-
pendent experiments. *p < 0.05.
(F) Percentage of Pax7-positive cells in TAmuscles
as in (E).
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D3 and the TH Signaling in Muscle Stem Cellsselenocysteine insertion sequence (SECIS) element and inacti-
vation of D3 (see Experimental Procedures), without affecting
D3mRNA levels (Figure S1D) in agreement with the genetic strat-
egy used.
We crossed the dio3 floxed mouse with a Tg:Pax7-CreERT2
mouse (Mourikis et al., 2012) in order to specifically delete D3
in the satellite cells. We subjected 2-month-old dio3fl/fl;
Tg:Pax7-CreERT2 mice (cD3KO) to tamoxifen (TAM) treatment
followed by CTX injury (Figure 3A). After TAM treatment, D3 in
satellite cells was markedly and specifically reduced as demon-
strated by immunofluorescence staining (Figures 3B and S3). As
expected, D3 protein levels were significantly reduced, but not
abolished, in muscle by TAM treatment, in agreement with the
expression of D3 in Pax7-negative cells, e.g., in infiltrating mac-
rophages (Figures 2B and 3B). Thus, the cD3KO mice sustained
specific postnatal D3 depletion specifically in Pax7-positive
cells.
D3 Depletion Causes Massive Apoptosis of Pax7-
Expressing Cells, Impairment of the Initial Wave of
Muscle Regeneration, and Failure of the Repair Process
After CTX injection (4 days), the pattern of regeneration in the
TA was similar in the control and cD3KO mice. However,
following D3 depletion at day 7 post-CTX, we observed a signif-
icant reduction in the number of Pax7-positive cells (Figures
3A–3C). This reduction was due to massive apoptosis, as
measured by TUNEL assay and PARP cleavage in regenerating
muscles (Figures 3C–3F, S3D, and S3E). Examination of muscle
sections at later times showed a striking difference between theCell Metabolism 20, 1038–1048, DcD3KO and wild-type (WT) animals, a
difference particularly evident at day 14
postinjury and thereafter (Figure 4A).
Indeed, while regeneration was active at
this time in control muscle, with most of
the myonuclei in the central position of
myofibers and a sharp increase in the
myogenic markers MyoD, Myogenin,and MHC, these markers were greatly decreased in cD3KO
muscles (Figures 4B and 4C). There was also a dramatic reduc-
tion in the number of regenerating fibers in the mutant animals
(Figure 4D), which is consistent with a block in the initial wave of
muscle regeneration. At day 40, when regeneration was almost
complete and the number of centrally located nuclei was similar
in the cD3KO and WT mice (Figure 4D), regeneration was
persistently aberrant and incomplete in the mutant tissues (Fig-
ure 4A). In addition, the cross-sectional area was significantly
reduced in cD3KO mice versus control mice (Figure 4E).
Systemic hypothyroidism significantly rescued apoptosis in
cD3KO mice (Figures 3D–3F), indicating that apoptosis was
due to an excessive intracellular TH concentration. Overall,
these results indicate that D3 depletion in satellite cells and
the consequent cell apoptosis significantly impair the regener-
ation process.
D3Depletion, aswell as Excessive TH, CausesCaspase-
3-Dependent Apoptosis in Activated Satellite Cells
In dio3fl/fl myoblasts, apoptosis followed D3 depletion or TH
treatment (Figures 5A, 5B, S4A, and S4B). This did not occur in
Adeno-Cre-infected cells from WT mice or in the fibroblast-like
primary cell population from dio3fl/fl mice (Figures S4C–S4F).
Since D3 serves only to inactivate TH, we speculated that
apoptosis would not occur in the absence of TH in the serum,
which was in fact the case (Figure 5A). Furthermore, apoptosis
was dependent on, and related to, cell proliferation. When differ-
entiated dio3fl/fl cells were infected with the Adeno-Cre virus or
treatedwith supraphysiological TH concentrations, no apoptosisecember 2, 2014 ª2014 The Authors 1041
Figure 4. D3 Depletion Impairs Muscle
Regeneration
(A) Histological analysis (H&E staining) of the TA of
control and cD3KO mice 4, 14, and 40 days after
CTX injection.
(B) Expression of myogenic markers MyoD,
Myogenin, and MHC measured by IF of the injured
TA muscles at day 14 as in (A).
(C) Confirmation of decreased expression of
MyoD, Myogenin, and nMyHC confirmed by
RT-PCR (top) and western blot analysis (bottom)
from the same muscles as in (B).
(D) Percentage of centrally located nuclei evalu-
ated in H&E-stained TA sections from WT and
cD3KOmice 4, 14, and 40 days after CTX injection.
(E) Cross-sectional area of TA sections from WT
and cD3KO mice 14 days after CTX injection.
Results are representative of at least three inde-
pendent experiments. Scale bar, 100 mm.
For (C) and (D) data are expressed as mean ± SEM
of at least three independent experiments.
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D3 and the TH Signaling in Muscle Stem Cellswas detected, nor did apoptosis occur in cells arrested in S
phase before TH treatment (Figures S4G and S4H). These results
indicate that proliferating, but not cell cycle-arrested or differen-
tiated, mpcs, undergo apoptosis following exposure to elevated
TH concentrations. Accordingly, in cultured fibers, TH treatment
significantly induced apoptosis in proliferating myoblasts (Fig-
ures S4I and S4L).
Finally, we tested whether apoptosis occurred also in vivo af-
ter TH treatment. In CTX-injured TH-treated mice, impairment of
the regeneration process (Figures S5A–S5C) was associated
with a significant reduction in Pax7-positive cells and a corre-
sponding increase in apoptosis (Figures 5C and 5D). Interest-
ingly, after TH treatment, the expression levels of TH-regulated
myogenic markers were normally increased in uninjured muscle,
but not in CTX muscle (Figure S5D). This finding is in agreement
with the concept that systemic thyrotoxicosis causes massive
apoptosis of activated myogenic precursor cells. These results
demonstrate that D3 expression protects activated satellite cells
from a physiological, but spatiotemporally excessive, intracel-
lular TH concentration.
FoxO3 Is a Novel TH-Responsive Gene in Myoblasts
To identify the molecular mechanisms underlying D3-dependent
apoptosis, we evaluated the effects of D3 depletion on the
expression of various transcription and myogenic factors. D31042 Cell Metabolism 20, 1038–1048, December 2, 2014 ª2014 The Authorsdepletion was associated with a spike
in TH-dependent signaling (Figure S5E)
and a transient induced transcription of
differentiation markers (Figures 6A and
6B), which is in agreement with the
marked similarity between the apoptotic
cascade and muscle differentiation (Fer-
nando et al., 2002). Interestingly, FoxO3
was significantly induced upon D3 deple-
tion in vitro and confirmed in vivo (Figures
6A, S5F, and S5G). The upregulation of
FoxO3 preceded the peak of MyoD, awell-established TH-responsive gene, thereby confirming data
showing that FoxO3 induces MyoD in muscle cells (Hu et al.,
2008) (Figures 6A and 6B).
To verify that TH induces FoxO3 levels, we measured the
response of FoxO3 to TH treatment in myogenic cells. FoxO3
was induced by TH at mRNA and protein levels (Figure 6C).
This effect was abrogated when a dominant-negative TH recep-
tor (TRPV) was transfected (Figures 6D and S4B), which indicates
that it requires a functional TR. TH also significantly increased
FoxO3 transcriptional activity, as demonstrated by the signifi-
cant increase in the activity of a FoxO3-responsive artificial
promoter upon treatment with TH, as well as its reduction by
intracellular T3 depletion obtained by reverse T3-mediated (Den-
tice et al., 2010) blockade of D2 (Figure 6E). Importantly, the
dependence of FoxO3 on TH levels was confirmed in vivo by
the appropriate FoxO3 levels in both hypo- and hyperthyroid
muscles (Figure 6F). Interestingly, FoxO3 was reduced in
D2KO cells and muscles (Figures 6G and 6H), in which intracel-
lular T3 concentrations are reduced, despite normal circulating
T3 (Marsili et al., 2011), indicating a direct correlation between
intracellular TH and FoxO3 levels.
In summary, this set of experiments provides compelling
evidence that TH is a master regulator of FoxO3 and demon-
strates that FoxO3 responds to the modulation of TH signaling
in muscle.
Figure 5. D3 Depletion Causes Massive
Apoptosis of Activated Myogenic Precursor
Cells
(A) Proliferating primary myogenic precursor cells
from cD3KO mice infected with CRE-expressing
adenovirus (Ad-CRE) or control GFP (Ad-GFP).
Apoptosis measured by western blot analysis of
PARP cleavage (right panels).
(B) FACS-sorted Pax7-GFP-positive cells exposed
to TH for the indicated times and apoptosis
assessed by measuring Annexin-V FACS profile.
(C) Immunostaining of Pax7- and TUNEL-positive
cells in TA of untreated control mice and TH-
treated mice (n = 3 CTR, n = 3 TH; experiments
were run three times).
(D) Pax7-positive and TUNEL-positive cells from
the same experiment as in (C). Data are expressed
as mean ± SEM of at least three independent
experiments.
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FoxO3-MyoD Axis
To assess the functional relevance of the FoxO3-MyoD axis in
TH-dependent apoptosis, we analyzed separately the roles of
FoxO3 and MyoD in TH-treated cells. Interestingly, TH failed
to induce apoptosis in cells expressing a dominant-negative
FoxO3 protein (Figures 7A and S4B) and in myoblasts geneti-
cally depleted of FoxO3 (Figures 7B and 7C), which indicates
that FoxO3 plays a crucial role in TH-induced apoptosis. We
also assessed the effects of TH in myoblasts in which MyoD
expression was efficiently blocked by RNAi (Figures S6A and
S6B). Again, TH failed to induce apoptosis (Figures 7D and
7E). This result indicates that an active MyoD is also required
for TH-induced apoptosis, and is consistent with a linear
cascade in which TH induces FoxO3, which lies upstream of
MyoD. Consistent with this model, both FoxO3 and MyoD defi-
ciency were rescued by transfecting a constitutively active
pAKT-resistant FoxO3 (Figure 7C) as well as by MyoD over-
expression (Figure S6B), thereby restoring in both cases the
capacity of TH to induce apoptosis. These gain- and loss-of-
function analyses clearly indicate that FoxO3 is a critical medi-
ator of the apoptosis driven by TH.
Finally, we asked whether TH-mediated muscle differentiation
also requires an intact FoxO3. The expression of several well-
known T3-dependent myogenic markers was not responsive
to TH in FoxO3-depleted cells (Figure 7F), and this was not
due to altered expression of TH receptors (Figure S6C). These
results indicate that FoxO3 is a critical mediator of TH action
in skeletal muscle and that, notwithstanding exposure to exces-
sive TH, FoxO3-depleted myoblasts do not undergo apoptosis
upon TH treatment and are phenotypically hypothyroid at nu-
clear level.Cell Metabolism 20, 1038–1048, DDISCUSSION
Here we report that D3 is a survival factor
for proliferating satellite cells. We show
that a time-dependent and cell-autono-
mous degradation of TH signaling via D3
expression is required for correct satellitecell amplification and muscle repair. In the absence of D3, prolif-
erating myoblasts undergo apoptosis, and this is functionally
critical in regenerating muscle, but less evident under homeo-
static conditions (Figure S7). To our knowledge, this study is
the first to describe how a ubiquitous endocrine signal—TH—is
integrated and adapted in the stem cell niche to enable cell line-
age progression.
In muscle stem cells, only activated proliferating cells apo-
ptose, not those that are quiescent or arrested in S phase (Fig-
ure 5). We previously demonstrated (Dentice et al., 2010) that
‘‘physiological’’ T3 is too low to allow proper cell differentiation.
Therefore, differentiating cells express D2 in order to locally pro-
duce extra T3 to allow proper differentiation. Vice versa, prolifer-
ating myoblasts require lower than circulating TH levels, and to
this aim activate D3-mediated T3 inactivation. This mechanism
protects them from apoptosis induced by the ‘‘excessive’’ levels
of T3 present in the plasma. Therefore, satellite cells are able to
customize their intracellular T3 concentrations based on their
functional state and dynamic needs. It is not yet clear why this
is the case, but we speculate that temporally excessive TH
creates a metabolic or mitotic catastrophe, which cannot be
overcome by the proliferating cells.
In vitro, D3 is potently induced by growth factors (EGF, FGF,
and PDGF) and cytokines (Dentice et al., 2009). We demon-
strated in neoplastic contexts that the Wnt and Shh pathways
are potent inducers of Dio3 (Dentice et al., 2009; Dentice
et al., 2012). No upstream regulators of D3 in myoblasts are
known. In the present study, we found that b-catenin, Sonic
Hedgehog, c-Met, cMyc, and Pax7 induced D3 in myoblasts
in vitro (Figure S6D). It is conceivable that D3 is induced by a
set of integrated signals from growth factors, cytokines, mor-
phogens, and other signaling pathways that are active at theecember 2, 2014 ª2014 The Authors 1043
Figure 6. Increased TH Signal Activates a Proapoptotic Cascade Involving FoxO3 and MyoD
(A) Time-dependent induction of TH target genes after Ad-CRE-induced D3 depletion in mpc cells from cD3KO mice or WT mice as indicated.
(B) FoxO3 and MyoD mRNA measured by RT-PCR in the same samples as in (A).
(C) FoxO3 mRNA (bottom) and protein (top) in TH-treated mpc from WT mice.
(D) FoxO3 mRNA measured by RT-PCR in the Mpc from WT mice transfected with empty vector (CMV-FLAG) or TRb dominant-negative-expressing plasmid
(TRPV) as indicated. Top: FoxO3 protein levels were measured by western blot analysis in the same samples.
(E) FoxO3 transcriptional activity measured in proliferating (PROL) and differentiating (DIFF) mpc treated with TH or rT3 and transfected with the FoxO3-
responsive promoter (DBE-LUC) and CMV-Renilla plasmids as internal standard. The LUC/Renilla value from untreated, proliferating cells was arbitrarily set as 1.
Data are expressed as mean ± SEM of at least three independent experiments. *p < 0.05.
(F) FoxO3 mRNA from WT mice untreated (EU), treated with TH (HYPER), or treated with MMI and KClO4 (HYPO) as indicated (see Experimental Procedures).
(G) FoxO3 mRNA levels in mpc from control (WT) and D2KO mice measured by RT-PCR.
(H) FoxO3 mRNA from WT and D2KO muscles at different postnatal days as indicated.
For (B)–(H) data are expressed as mean ± SEM of at least three independent experiments.
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D3 and the TH Signaling in Muscle Stem Cellsinjury site. Dissecting their specific role will be the object of
future studies.
T3 is a circulating hormone whose plasma concentrations are
relatively stable in the healthy state. In plasma, the hypothalam-
ic-pituitary-thyroid axis prevents potentially adverse oscillations
of T4 and T3 via a potent homeostatic mechanism that controls1044 Cell Metabolism 20, 1038–1048, December 2, 2014 ª2014 Thehormone secretion by the thyroid gland (Bianco and Kim, 2006).
A major question in this context is how muscle stem cells
customize their TH signature and adapt it to their physiology.
The rapid increase in D3 in proliferating muscle stem cells and
the consequent attenuation of T3 nuclear receptor saturation is
an ideal solution to this problem.Authors
(legend on next page)
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D3 and the TH Signaling in Muscle Stem CellsThe local metabolism of TH is a highly regulated process dur-
ing embryonic and fetal life, as well as during muscle regenera-
tion. In general, D3 is reciprocally regulated with D2 to maintain
local control of the T3 concentration. These interlocking
pathways facilitate specific chronotropic and tissue-specific
changes in T3 concentrations during periods when develop-
mental or regenerative programs call for a transient increase or
decrease in specific cells (Gereben et al., 2008). The rapid in-
crease of D3 in proliferating myoblasts clearly indicates that
the ambient plasma and cellular concentrations of TH are too
high to sustain their proliferation. D3 is also expressed in
activated macrophages at the injury site (Boelen et al., 2011),
although its role in this cell context is presently unknown. This
mechanism also occurs in the mdx mouse model, where D3 is
expressed at significantly higher levels compared with healthy
muscle (Figure 1D).
Skeletal muscle stem cells are a heterogeneous population of
cells that span from stem-like cells to cells more committed
toward myogenic lineage progression and differentiation. There
are at least two populations of Pax7-positive satellite cells resi-
dent in skeletal muscle. One population rapidly contributes to
muscle repair; the second is more stem cell-like and remains
longer in a quiescent state in the recipient muscle. These func-
tional differences are reflected by the different levels of Pax7
(Rocheteau et al., 2012). In this context, Pax7Hi represents a
reversible dormant stem cell state during homeostasis (Mourikis
et al., 2012).Hereweshow that T3availability is differentially regu-
lated in these twosubpopulationsofmyogenic cells viaD3 action.
During muscle homeostasis, D3 is expressed in the satellite cells
that are poised for myogenic commitment (Pax7Lo), wherein D3
expression does not simply reflect a secondary homeostatic
regulation of this enzyme, but causes an intracellular attenuation
of the TH signal compared to the Pax7Hi cells. This is reflected in
the divergent expression of oppositely regulated TH-responsive
genes, which change depending on the reduced TH signaling
mediated by D3 (Figures 2E and 2F). Such a regulation could
correlatewith themetabolic status of the cells, e.g., Pax7Lo quies-
cent cells are more metabolically active than the corresponding
Pax7Hi (Rocheteauet al., 2012). This raises intriguing issues about
whether and howT3 signalingmight influence stemness.Herewe
show that the control of TH signaling in themuscle stemcompart-
ment occurs, and that it is necessary for muscle cell lineage pro-
gression. This is in agreement with the critical role of TH action in
neurons, where TH signaling represses Sox2 levels and regulates
neurogenesis (Lo´pez-Jua´rez et al., 2012).
Hyperthyroidism in humans may cause a severe muscle
myopathy associated with a failure in muscle regeneration (An-Figure 7. The FoxO3-MyoD Axis Is Required for TH-Induced Apoptosis
(A) Mpc fromWT mice transiently transfected with empty vector (CMV-FLAG) or F
TH. Apoptosis was measured based on western blot of PARP cleavage.
(B) Western blot analysis of PARP cleavage in mpc from WT and FoxO-KO mice
(C) PARP cleavage in mpc from FoxO-KO mice. Cells were transfected with emp
(D)Mpc fromWTmice transiently transfectedwith control iRNA oligonucleotides (i
as indicated. PARP cleavage was evaluated by western blot from total lysates a
(E) Representative images of the same cells as in (D).
(F) TH target gene expression in mpc fromWT and FoxO-KOmice treated or not w
gene, normalized copies of the target gene in untreated (CTR) cells from WT mice
independent experiments.
(G) The TH-FoxO3-MyoD axis promotes apoptosis in activated myogenic precur
1046 Cell Metabolism 20, 1038–1048, December 2, 2014 ª2014 Thederson et al., 1994; Simonides and van Hardeveld, 2008). While
it was thought that the effects of hyperthyroidism occurred at the
level of myofibers (Simonides and van Hardeveld, 2008), the
reduced expression of Pax7 and increased apoptosis in hyper-
thyroid muscle in mice characterized in this study point to a fail-
ure at stem cell level, which may well occur also in humans.
Here we show that FoxO3 is a positively regulated down-
stream effector of TH signaling. Importantly, the identification
of FoxO3 as a T3 target links two potent systems controlling
multiple aspects of muscle physiology. In silico examination of
the mouse FoxO3 locus showed multiple potential candidate
sequences containing TR-binding elements, although none
was evolutionally conserved, and ChIP assays failed to identify
functional relevance under our experimental conditions. Never-
theless, the accumulating evidence indicating crosstalk between
T3 and the AKT pathway (Figure 6) points to a complex network
involving FoxO3 regulation by T3. Intriguingly, FoxO3 is a potent
inducer of D2—the T3-producing enzyme—thus suggesting that
a positive autoregulatory loopmight be onemechanism bywhich
FoxO3 is a target of T3, and also indirectly sustains T3 intracel-
lular concentration by inducing D2 (Figure 7G).
Asakura and colleagues suggested that MyoD is a proapopto-
tic transcription factor in muscle stem cells (Asakura et al., 2007).
Here we show thatMyoD, a target of both T3 and FoxO3 (Dentice
et al., 2010; Hu et al., 2008), is required for the proapoptotic
cascade triggered by T3. Finally, we show that not only does
FoxO3 act as a TH target, but also that its action is required to
sensitize muscle stem cells to TH levels.
In summary, the absence of D3 in activated muscle stem cells
causes a time-dependent and irreversible stem cell death due to
excessive intracellular nuclear T3. D3 depletion renders these
cells incapable of overcoming the T3 excess, thus promoting
the apoptotic pathway. The finding that D3 plays a crucial role
in controlling nuclear T3 inmuscle stem cells and in the triggering
of a death pathway via the FoxO3-MyoD axis has broad implica-
tions and opens a future research scenario for the development
of translational therapeutic strategies based on the local control
of potent endocrine signals by modulating their metabolic
pathways.
EXPERIMENTAL PROCEDURES
Cell Cultures, Transfections, and Reagents
Primary muscle cultures (pp6) were isolated as described (Qu et al., 1998) from
the indicated mouse lines. FoxO3-depleted (FoxO-KO) pp6 cells were pre-
pared from foxO3+/ mice as previously described (Dentice et al., 2010).
C2C12 cells were obtained from ATCC. In some experiments, endogenous
T3 and T4 were removed from the FBS by charcoal absorption (Larsen,oxO dominant-negative (FoxOd.n.) expression plasmid and treated or not with
treated or not with TH.
ty vector or FoxO3 expression vector and treated or not with TH as indicated.
CTR) or oligonucleotide for specificMyoD silencing (iMyoD) and treatedwith TH
s marker of apoptosis.
ith TH evaluated by RT-PCR. Cyclophilin A served as internal control. For each
were arbitrarily set as 1. Data are expressed as mean ± SEM of at least three
sor cells.
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D3 and the TH Signaling in Muscle Stem Cells1972). Transient transfections were performed using Lipofectamine 2000 (Life
Technologies) according to the manufacturer’s instructions. Single myofibers
were prepared from the extensor digitorumlongus and gastrocnemiusmuscles
of 6- to 12-week-old mice as previously described (Rosenblatt et al., 1995).
Pax7Hi-Lo isolation by FACS has been described elsewhere (Rocheteau
et al., 2012). Anti-MyoD (sc-304), myogenin (sc-12732), tubulin (sc-8035),
and anti-FoxO3 antibodies were purchased from Santa Cruz Biotechnology.
Polyclonal anti-MHC antibody (MF-20a) and anti-Pax7 antibody were from
Developmental Studies Hybridoma Bank. Anti-D3 antibody is described else-
where (Huang et al., 2003). Anti-Desmin antibody was from MP Biomedicals
(#10519). Anti-total Akt was from Upstate, and anti-pAkt and anti-PARP
were from Cell Signaling Technology. TUNEL assay was performed using
the ApopTag kit from Millipore. Caspase-3/Caspase-7 activity was measured
by using the CaspaseGlo kit from Promega.
FACS-Sorted Satellite Cells
Cells isolated by FACS were prepared from Tg:Pax7-nGFP mice as previously
described (Rocheteau et al., 2012). In brief, muscle dissection was done
with a scalpel by removing the tissue from the bone in DMEM. Muscles were
then chopped and digested with collagenase 0.1% and trypsin 0.25% at
37C. The collagenase/trypsin solution was added to continue the digestion
until the process was completely terminated and muscle totally digested.
Satellite cells have been cultured in 1:1 DMEM:MCDB containing 20% serum
FBS and ITS (1 3, Insulin-Transferrin-Selenium; Gibco). Cells were plated on
Matrigel (BD Biosciences; catalog #354234) or collected in a lysis buffer
(RNeasy Micro Kit, Quiagen) for RNA extraction. Cells were prepared for
FACS analysis using a MoFlo (Beckman Coulter).
Plasmids and Expression Constructs
FoxO3, FoxOdn, and DBE plasmids are described elsewhere (Dentice et al.,
2010). TRPV plasmid was kindly provided by Dr. S. Cheng. To knock down
MyoD, two different Stealth siRNA targeting two different regions of the coding
sequence (MyoD-7, GACGACUUCUAUGAUGACCCGUGUU; and MyoD-8,
CACUACAGUGGCGACUCAGAUGCAU) were designed with the Block-iT
technology (Invitrogen) and purchased from Invitrogen Corporation. Effective
MyoD knockdown was assessed by measuring endogenous MyoD levels in
satellite cells following 48 hr Stealth siRNA transfection (Figure S6A).
Generation of the cD3KO Mouse Model
All three deiodinases contain a critical selenocysteine residue in the catalytic
domain, which is encoded by a UGA codon and requires a specific second-
ary mRNA loop (SECIS element) in the 30 UTR of the mRNA that overrides the
stop function and inserts selenocysteine (Berry et al., 1991). Given the abso-
lute requirement of a SECIS element for correct D3 protein translation, we
selectively ablated the SECIS region in the dio3 gene, thus preserving the
dio3as transcript encoded in the antisense orientation in the dio3 locus,
the function of which is not known (Figure S2). We generated a plasmid
harboring floxed sites in the dio3 locus, and specifically flanking the SECIS
mRNA structure located at nt 1,001 and nt 1,706 from the ATG in the dio3
mRNA (Figure S2). In the absence of the SECIS, the TGA codon, within the
D3 catalytic domain, is recognized as stop codon, and protein translation
terminated. Once we obtained the homozygous dio3fl/fl mice, we crossed
these mice with heterozygous Tg:Pax7-CreERT2 mice, expressing the Cre-
ERT2 fusion protein. The Cre-ERT2 protein consists of Cre recombinase
fused to a triple-mutant form of the human estrogen receptor and catalyzes
the lox sites recombination TAM inducible. The expected recombination
event occurred in the progeny, as documented in the PCR in Figure S1D. Di-
o3fl/fl not expressing recombinase, but TAM treated, were used as negative
controls.
Immunofluorescence and Immunohistochemistry
For immunofluorescent staining, cells were fixed with 4% formaldehyde and
permeabilized in 0.1% Triton X-100, then blocked with 0.5% goat serum
and incubated with primary antibody. Dissected muscle was snap frozen in
liquid nitrogen, sectioned (7 mm thick), and stained with hematoxylin and eosin
stain (H&E) or immunofluorescence using standard protocols. Alexa 595-con-
jugated secondary antibody was used. Images were acquired with an IX51
Olympus microscope and the Cell*F software. Images were assembled usingCell MetabAdobe Photoshop. Western blots were run in triplicate, and bands were quan-
titated in one representative gel.
Muscle Regeneration Studies
CTX was injected as described previously (Yan et al., 2003). Briefly, 10–20 ml of
10 mM CTX (Naja mossambica mossambica, Sigma-Aldrich) was injected into
the right TA and gastrocnemius muscles of anesthetized 12-week-old C57BL/
6 male mice (The Jackson Laboratory) (WT), and age- and gender-matched
cD3KO mice. The uninjected left TA muscles served as controls. For CTX
experiments in cD3KO mice, animals were treated daily with 75 mg/g TAM
for 5 days, and CTX was injected on day 4. Mice were killed 4, 14, or
40 days after CTX injection. For CTX experiments in WT mice, animals were
treated daily with TH (2.5 mg/mouse T3 + 10 mg/mouse T4) 4 days before
CTX injection; mice were killed 4 and 14 days after CTX injection. Hypothyroid-
ism was obtained by supplying the drinking water with 0.1% MMI and 1%
KClO4 for 6 weeks. Animal experimental protocols were approved by the
Animal Research Committee of the University of Naples Federico II.
Statistical Analysis
Errors quoted are SEM throughout. Differences between samples were
assessed by the Student’s two-tailed t test for independent samples. In all
experiments, differences were considered significant when p was less than
0.05. Asterisks indicate significance at *p < 0.05, **p < 0.01, and ***p < 0.001
throughout.
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